01Handling versus taking the tablet
A woman who may be pregnant should not handle crushed or broken tablets. A woman is also not the labelled patient for the swallow. Those are two stops, not one.
If she only touched a whole coated tablet, that is ordinary handling the coat is meant to cover. Chips and dust are the exposure the warning names.
02Why pregnancy is a contraindication, not a footnote
PROPECIA is contraindicated in women who are or may become pregnant. Type II blockade can disrupt male genital development. That is Category X language on this label.
Handling crushed tablets is the skin path. Swallowing the tablet in pregnancy is not a labelled option either.
03Are children on this 1 mg label?
No. PROPECIA is not indicated in pediatric patients. Do not park a 1 mg bottle in a house as a shared 'hair vitamin'.
Keep the closed container away from children. Storage is 15-30 C, container closed, protected from moisture.
04What the indication sentence actually says
PROPECIA is indicated for male pattern hair loss in men only. It is not indicated for use in women. Pediatric patients are also outside the indication.
A social-media protocol for 'female pattern hair' is not this label. The 1 mg vault stays on the men's row.
05Does a Finpecia 1 mg ad create a women's dose?
No. Export marketing does not rewrite Indications. If a page sells Finpecia 1 mg 'for her', it is off this label.
Name matching lives on the INN note when the carton says finasteride 1 mg. It does not add a sex.
06What the 137-woman study measured
Twelve months. Hair counts, patient self-assessment, investigator assessment, and standardized photographs. None of those improved on PROPECIA compared with placebo in that postmenopausal group.
Negative on four reads is why the indication did not expand. It is not a small 'maybe' the ads forgot.